Influenza-related Pneumonia
- HPA guidance: antivirals for influenza
Severity (classification)
|
1st line oral/iv antibiotics
|
Anaphylactic penicillin allergy (see explanatory notes)
|
A Minor to moderate infection
Review doses in renal impairment
|
DOXYCYCLINE 200mg po od OR
CO-AMOXICLAV 625mg po tds
Treatment duration: typically 5 days
|
DOXYCYCLINE 200mg po od OR
CLARITHROMYCIN 500mg po bd
Treatment duration: typically 5 days
|
B/C
Moderate to severe life threatening infection
Review doses in renal impairment
|
CO-AMOXICLAV 1.2g iv tds plus
CLARITHROMYCIN 500mg bd iv/po
OR
If definite history of rash allergy but no anaphylactic penicillin allergy (see explanatory notes) use:
MEROPENEM 1g iv tds plus
CLARITHROMYCIN 500mg bd iv/po
If suspected/confirmed MRSA add: TEICOPLANIN 400mg iv every 12 hours for 3 doses then 600mg iv once daily and review with microbiologist
Maintain treatment pending pre-dose (trough) level on Day 5
Mild to moderate infection (10-20mg/l)
Severe(>20mg/l,<60mg/l)
Re-assay after 6 to 8 days
Total treatment duration (including oral step-down): typically 7-14 days
|
LEVOFLOXACIN 500mg po bd
(iv only if critically ill / NBM)
Total treatment duration (including oral step-down): typically 7-14 days
|
IV to Oral Switch
(explanatory notes)
|
CO-AMOXICLAV 625mg po tds plus
CLARITHROMYCIN 500mg bd
|
Age ≤ 65 yrs LEVOFLOXACIN 500mg po bd Age > 65 yrs DOXYCYCLINE 200mg po od
|
If MRSA positive: typically DOXYCYCLINE 200mg od, discuss with microbiologist if severe infection Total antibiotic duration typically 7-14 days
[NB antiviral therapy, oseltamivir (Tamiflu®) or zanamivir (Relenza®) typically to complete 5 days]
- HPA guidance: antivirals for influenza
|
For guidance on the administration of intravenous antibiotics
click here (GHNHSFT intranet only)